Not available
Quote | Immunomedics Inc. (NASDAQ:IMMU)
Last: | $87.86 |
---|---|
Change Percent: | 0.05% |
Open: | $87.85 |
Close: | $87.86 |
High: | $87.93 |
Low: | $87.59 |
Volume: | 15,282,019 |
Last Trade Date Time: | 10/22/2020 04:56:50 pm |
News | Immunomedics Inc. (NASDAQ:IMMU)
This article focuses on the major influences towards a biotech company's share price, rather than their value or opportunity. These catalysts will be important to consider when timing your entry and exit points. This article will be the last that focuses on evaluating individual h...
Soros' 13F portfolio value increased from $4.08B to $5.30B this quarter. The number of positions increased from 132 to 146. Soros added Clarivate plc and Elanco Animal Health while dropping DraftKings and E*TRADE Financial. Liberty Broadband at ~16% of the portfolio is by far the ...
Message Board Posts | Immunomedics Inc. (NASDAQ:IMMU)
Subject | By | Source | When |
---|---|---|---|
Time to start loading for the long term | ilovestocks85 | investorshub | 10/24/2020 4:25:16 AM |
Piper boosts Gilead $GILD target to $95 from | BottomBounce | investorshub | 10/24/2020 1:13:53 AM |
NEWS -- Laboratory Testing of Brilacidin for COVID-19 | Here Today | investorshub | 09/15/2020 1:50:40 PM |
whytestocks: $IMMU News Article - Should You Buy Gilead Now That It's Acquiring Immunomedics? | whytestocks | investorshangout | 09/15/2020 12:00:48 PM |
JUST IN: $IMMU Should You Buy Gilead Now | whytestocks | investorshub | 09/15/2020 11:46:09 AM |
News, Short Squeeze, Breakout and More Instantly...
Gilead Sciences (NASDAQ: GILD) can be both a hero and a goat, depending on your perspective as an investor. The stock price rose from $17 in July 2010 to $118 in July 2015, as the company introduced revolutionary HIV drugs and helped bring a cure for hepatitis C to market. Since the...
With huge investments being made in biotech thanks to the pandemic, there has been a renewed focus on biotech stocks. Here are three worth considering: Amgen (AMGN), Immunomedics (IMMU), Seattle Genetics (SGEN), and Genmab (GMAB). The biotechnology industry has rightfully received a huge ...
MORRIS PLAINS, N.J., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced that the Office of Orphan Products...